MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System
Rhea-AI Summary
MedWell Ai (OTCQB: MWAI) signed a Letter of Intent to form a vertically integrated regenerative wellness platform organized into three divisions: national pharma distribution and telemed, surgical and cosmetic centers with a men's franchise, and advanced biologics/product innovation.
The consolidation targets Ageless Cosmetic Surgery Centers, Apollo BioWellness (OTC: KOAN) and Evolutionary Biologics, plus MedWell USA. Trailing 2025 revenues totaled $14 million; the consolidated company is projected to exceed $25 million in 2026 with conservative EBITDA margins ≥20%, subject to funding and successful closings within a targeted 60 days.
Market context cites a USD 35.5B regenerative medicine market in 2024, expanding toward USD 169B by 2034 and a USD 6.3T global wellness economy in 2023.
Positive
- Trailing revenue of $14M in 2025
- Projected consolidated revenue > $25M in 2026 (assumes funding)
- Targeted conservative EBITDA ≥20%
- Planned vertical integration across distribution, clinics, and biologics
Negative
- Projections are conditional on adequate funding and successful closings
- Current status is an LOI with due diligence underway; transactions are not closed
- Planned close window of 60 days is aggressive and may face execution risk
News Market Reaction – MWAI
On the day this news was published, MWAI declined 0.02%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
CLEARWATER, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN – MedWell Ai, Inc ("Company") (OTCQB: MWAI) is pleased to announce the signing of a Letter of Intent (“LOI”) to create a vertically integrated health, wellness and longevity platform.
New MedWell Ai, Inc will be organized across three core divisions: (1) national pharma distribution and telemed platform, (2) nationwide portfolio of premium surgical and cosmetic centers and men’s healthcare franchise brand and (3) advanced biologics and product innovation group.
The Company will acquire, consolidate and operate the following divisions:
- Ageless Cosmetic Surgery Centers, Inc., headquartered in Garden City, NY.
- Apollo BioWellness, Inc. (OTC: KOAN) and its subsidiary Evolutionary Biologics, Inc and other aesthetic and cosmetic technologies and products.
- MedWell USA, LLC, currently operating and rapidly growing subsidiary, focused on:
- (1) Distribution of GLP-1 and Peptides based products, manufactured by 503B facilities
- (2) Soon to be launching TeleMD, LLC - 24/7 telehealth platform.
Based on trailing revenues of
All parties have begun the due diligence process with the goal of closing the transactions within 60 days.
- Market Size: The Global Regenerative Medicine Market, a core component of the regenerative wellness ecosystem, was valued at approximately USD 35.5 billion in 2024 and is projected to reach over USD 169 billion by 2034, growing at a CAGR of roughly
16% to23% . The broader global wellness economy, which includes elements of regenerative health, reached a record USD 6.3 trillion in 2023 and is forecasted to reach USD 9.8 trillion by 2029. - Projections: Market is anticipated to reach between USD 90 billion and USD 555 billion by 2032-2034, driven by advancements in stem cell therapies, gene editing, and tissue engineering. The industry is experiencing a robust CAGR, with estimates generally falling between
16% and31% . - Market Drivers: North America is the leading market, accounting for over
58% of the global market share in 2024, supported by high healthcare spending and advanced biotech infrastructure. The U.S. market is projected to surpass USD 80 billion by 2033. Stem Cell and Gene Therapy: These subsegments are witnessing the fastest growth due to increased investment and regulatory approvals for treating genetic and degenerative disorders.
Steve Rubakh, CEO of MedWell Ai, comments:
“I am pleased to announce this consolidation to create a world-class state-of-the-art regenerative wellness company. By owning and aligning distribution, laboratories, biologics, and retail care models, MedWell Ai will create a complete wellness eco-system, designed to reduce supply chain inefficiencies, strengthen quality control, improve reliability, and enable disciplined national expansion through a scalable operating strategy. With the proposed consolidation, the Company intends to announce shortly, bringing a seasoned and talented management team to operate all three verticals. In addition, the Company is entertaining other additional strategic acquisitions it will be targeting in the coming months, as part of our quest to make MedWell Ai the #1 Regenerative Wellness & Medical Platform in the World".
Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
InvestorWire Service Contact:
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com
FAQ
What did MedWell Ai (MWAI) announce on February 10, 2026 about business consolidation?
What are MedWell Ai's (MWAI) revenue and margin projections after the planned consolidation?
Which companies is MedWell Ai (MWAI) planning to acquire under the LOI?
What is the timeline for MedWell Ai's (MWAI) proposed transactions?
How large is the market opportunity MedWell Ai (MWAI) cites for regenerative wellness?
